Supernus Pharmaceuticals
SUPN
29,34 €
Share price
-3.27%
Change (1 day)
-6.02%
Change (1 year)
Categories
Market capitalization of Supernus Pharmaceuticals (SUPN)
Market cap: €1.63 Billion
As of April 2025 Supernus Pharmaceuticals has a market cap of €1.63 Billion. This makes Supernus Pharmaceuticals the world's 4431th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Supernus Pharmaceuticals from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €1.63 B | -17% |
| 2024 | €1.97 B | 37.94% |
| 2023 | €1.43 B | -20.44% |
| 2022 | €1.79 B | 31.28% |
| 2021 | €1.36 B | 26.62% |
| 2020 | €1.08 B | -2.78% |
| 2019 | €1.11 B | -26.78% |
| 2018 | €1.51 B | -10.77% |
| 2017 | €1.70 B | 43.17% |
| 2016 | €1.18 B | 97.42% |
| 2015 | €0.60 B | 105.39% |
| 2014 | €0.29 B | 34.35% |
| 2013 | €0.21 B | 31.52% |
| 2012 | €0.16 B |
End of Day market cap according to different sources
On Apr 1st, 2025 the market cap of Supernus Pharmaceuticals was reported to be:
€1.63 Billion
€1.63 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €1.38 B | -15.16% | 🇺🇸 USA |
 | €12.76 B | 679.47% | 🇺🇸 USA |
 | €669.65 B | 40,793.92% | 🇺🇸 USA |
 | €112.21 B | 6,752.72% | 🇺🇸 USA |
 | €211.51 B | 12,816.65% | 🇺🇸 USA |
 | €342.01 B | 20,786.14% | 🇺🇸 USA |